TScan Therapeutics (United States)
Research institution (company, US)
Press Enter · cited answer in seconds
0 sources
Financials
Self-reported XBRL data from 6 annual filings
Revenue
$10.32M
Net Income
-$129.77M
Assets
$228.79M
EPS (diluted)
$-1.00
■ Revenue ■ Net Income
Source: SEC EDGAR · latest 10-K filed 2025-12-31 · accession
0001193125-26-089884